Sign in
Facet browsing currently unavailable
Page 3 of 5932 results
Sort by: relevance publication year
|
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics |
|
Barriers and facilitators in uptake of human papillomavirus vaccine across English Canada: A review JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics |
|
COVID-19 risk perception, cognitive dissonance, and vaccine hesitancy JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics |
|
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics Research funded by National Natural Science Foundation of China (No. 82070604) | the Shanghai Municipal Key Clinical Specialty (shslczdzk01103) | the Shanghai Ruijin Hospital Three-Year Plan of the Clinical Skills and Innovations (2018CR005) |
|
Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics |
|
A preliminary study on the effectiveness of maternal to neonatal transfer of antibodies against SARS-CoV-2 in the women vaccinated with heterologous CoronaVac–ChAdOx1 JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics Research funded by Chiang Mai University (043/2565) |
|
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics Research funded by Taishan Scholar Program of Shandong Province (ts201511105) |
|
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18–49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics |
|
Multi-dimensional psychosocial factors influencing the willingness to receive a COVID-19 vaccine booster: A survey among the public in Mainland China JOURNAL ARTICLE published 30 November 2022 in Human Vaccines & Immunotherapeutics Research funded by Central Government Guiding Local Science and Technology Development (2021L3018) |
|
Heterologous mRNA-based COVID-19 booster strategies: Comment JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics |
|
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials JOURNAL ARTICLE published 3 July 2021 in Human Vaccines & Immunotherapeutics |
|
Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China JOURNAL ARTICLE published 30 November 2022 in Human Vaccines & Immunotherapeutics Research funded by Science and Technology Bureau of Quzhou, Zhejiang, China (Project No.:20172090) | Zhejiang Preventive Medicine Association, China (Project No.:2017YF03) |
|
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China JOURNAL ARTICLE published 2 January 2023 in Human Vaccines & Immunotherapeutics |
|
Development of a Spanish version of the parent attitudes about childhood vaccines survey JOURNAL ARTICLE published 4 May 2019 in Human Vaccines & Immunotherapeutics |
|
Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto Rico JOURNAL ARTICLE published July 2012 in Human Vaccines & Immunotherapeutics |
|
Waning of maternal antibody against measles virus in Shufu, China JOURNAL ARTICLE published 30 November 2022 in Human Vaccines & Immunotherapeutics Research funded by Guangzhou Science and Technology Bureau (201704020004) | The Key Project of Medicine Discipline of Guangzhou (2021–2023-11) |
|
Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats JOURNAL ARTICLE published 2 January 2017 in Human Vaccines & Immunotherapeutics |
|
Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants JOURNAL ARTICLE published 29 April 2022 in Human Vaccines & Immunotherapeutics |
|
Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models JOURNAL ARTICLE published 30 December 2022 in Human Vaccines & Immunotherapeutics |
|
Pneumococcal vaccination of older adults JOURNAL ARTICLE published 12 June 2013 in Human Vaccines & Immunotherapeutics |